American health insurance company ELV Anthem, Inc. was the previous name of Elevance Health before June 2022. The business offers a range of services through connected firms such Anthem Blue Cross and Blue Shield, Empire BlueCross BlueShield in New York State, Anthem Blue Cross in California, Wellpoint, and Carelon, including medical, pharmaceutical, dental, behavioral health, long-term care, and disability insurance. The Blue Cross Blue Shield Association’s largest for-profit managed healthcare organization is this one. The company’s health programs for its connected firms have 46.8 million members as of 2022. The company was rated 20th on the 2022 Fortune 500 based on its 2021 revenues.
As a provider of health benefits, ELV.
It helps people connect to the care, support, and resources they need to live healthy lives throughout the full care journey for individuals, families, and communities. Through a range of medical, digital, pharmacy, behavioral, clinical, and care solutions, it provides services to almost 118 million people.
In June 2022, Elevance Health Inc., which had previously been known as Anthem, Inc., became the official name of the business.
Indianapolis, Indiana serves as the home base for Elevance Health, Inc. which was established in 1944.
Prices
Anthem announced earnings of US$3.843 billion for the 2017 fiscal year, with US$90.039 billion in yearly revenue, an increase of 6.1% from the previous fiscal year. In October 2018, Anthem’s market capitalization was over US$69.1 billion and its shares were trading at over $183 per share.
REWARDS
- Trading for 62.8% less than what we believe to be its true value
- Earnings are anticipated to increase by 11.58% annually.
- Comparing trading at a good value with its competitors and industry
- Analysts generally concur that the stock price will increase by 33.5%.
Risk evaluation
- Our risk checks found no threats to Elevance Health, Inc.
Elevance Health’s market capitalization from 2010 until 2023. The market capitalization (or market value), which is calculated by dividing a company’s current stock price by the total number of outstanding shares, is the most often used metric to assess the size of a publicly traded company. Elevance Health’s market worth is $103.1 billion as of July 12, 2023.
Revenue and Profit
Elevance Health’s annual/quarterly sales history and growth rate from 2010 to 2023. Revenue is the amount of money received by a company from its customers in return for the sale of goods or services. Net income is computed by subtracting all costs and expenses from revenue, which is the top-line item on an income statement.
- Elevance Health, Inc. Health’s revenue for the quarter ending March 31, 2023, was $42.172B, up 10.7% from the same time the previous year.
- Elevance Health’s revenue for the fiscal year ended March 31, 2023, was $160.672 billion, an increase of 11.31% over the previous year.
- Elevance Health’s annual revenue in 2022 was $156.595 billion, a 12.95% increase over 2021.
Elevance Health’s yearly and quarterly gross earnings and growth rate from 2010 to 2023. The money a firm makes after deducting the variable expenditures directly associated with manufacturing, promoting, and selling its goods or providing its services is referred to as gross profit.
Elevance Health’s gross profit for the quarter ending March 31, 2023, was $7.905B, up 13.24% from the previous year.
Elevance Health’s gross profit for the fiscal year ending March 31, 2023, was $27.997B, up 8.91% from the previous year.
ELV Technical Analysis of Stock
- The Moving Averages Convergence Divergence (MACD) indicator forElevance Health, Inc. (ELV) is -5.79, indicating that Elevance Health is a Buy.
- With a share price of $414.13 and a 20-Day Exponential Moving Average of 443.61, Elevance Health (ELV) is classified as a Sell.
- With a share price of $414.13 and a 50-day exponential moving average of 451.71, Elevance Health, Inc. (ELV) is classified as a Sell.
Based on information from July 13, 2023, at 13:34, the general outlook for the ELV stock is bearish, with 24 bearish indications and 2 bullish signals being indicated by technical analysis indicators.
- The Relative Strength Index (RSI) for Elevance Health (ELV) is 42.00, indicating a Neutral signal.
- The Trend Strength Indicator (ADX) for Elevance Health (ELV) is 12.91, indicating a Buy.
- The Commodity Channel Index (CCI) for Elevance Health (ELV) is -98.68, producing a Neutral signal.
- The Price Rate of Change (ROC) for Elevance Health (ELV) is -0.69, generating a Sell signal.
It is beneficial to also look at the price history of Elevance Health Inc. to have a better sense of what might happen to the ELV stock price in the future. The ELV/USD pair has gained % over the previous month. The ELV/USD performance over a year is %. Elevance Health Inc. stock performed -35.77% worse than Bitcoin and -43.23% worse than Ethereum over the past year.
ELV Moving Average of Stock
- With a 10-Day exponential moving average of 438.81 and a share price of $414.13, Elevance Health (ELV) is classified as a Sell.
- With a share price of $414.13 and a 100-Day exponential moving average of 459.89, Elevance Health (ELV) is classified as a Sell.
- A sell signal has been generated by Elevance Health’s (ELV) stock price of $414.13 and its 50-day simple moving average of 452.87.
- A sell signal has been generated by Elevance Health’s (ELV) stock price of $414.13 and its 100-day simple moving average of 460.64.
- With a $414.13 stock price and a 200-day simple moving average of 476.88, Elevance Health, Inc. (ELV) has a sell signal.
One of the most widely used stock prediction methods for Elevance Health Inc. is the moving average. A moving average, as its name suggests, gives the average closing price for the ELV stock over a chosen time period, which is split into a number of segments of equal length. For instance, a 12-day simple moving average for ELV is calculated by adding together and dividing by 12 the closing prices for ELV over the previous 12 days.
The exponential moving average (EMA) is a different type of moving average that traders employ in addition to the simple moving average (SMA). The EMA responds to the current price movement more swiftly because it gives more weight to more recent prices.
Predictions
The predicted price for Elevance Health Inc. shares for tomorrow is $414.37, which would be 0.11% higher than the current price. The price of ELV is predicted to rise by 7.82% and reach $446.27 in the upcoming week.
Here is what our predictions now indicate for the long-term Elevance Health Inc. stock prognosis. These forecasts are based on ELV’s 10-year growth average.
- The future price target for Elevance Health Inc. stock is $ 321.13 (-22.42%) in a year.
- Stock prediction for Elevance Health Inc. for 2025: $623.72 (50.69%)
- 2030 price target for Elevance Health Inc. stock is $1,738.50 (320.04%)
